| Retrospective evaluation of the clinical utility of serological biomarkers in Chinese patients with inflammatory bowel disease: 2-year clinical experience | |
| Zhang Shulan; Luo Jing; Li Ji; Wu Ziyan; Hu Chaojun; Li Ping; Deng Chuiwen; Zhang Fengchun; Qian Jiaming; Li Yongzhe | |
| 2017 | |
| 卷号 | 55期号:6页码:865-875 |
| 关键词 | ASCA Crohn's disease (CD) pancreatic autoantibodies (PAB) perinuclear anti-neutrophil cytoplasmic (pANCA) serological biomarkers ulcerative colitis (UC) |
| ISSN号 | 1434-6621 |
| DOI | 10.1515/cclm-2016-0658 |
| URL标识 | 查看原文 |
| 收录类别 | SCIE ; PUBMED |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/6367373 |
| 专题 | 中国医学科学院 北京协和医学院 |
| 推荐引用方式 GB/T 7714 | Zhang Shulan,Luo Jing,Li Ji,et al. Retrospective evaluation of the clinical utility of serological biomarkers in Chinese patients with inflammatory bowel disease: 2-year clinical experience[J],2017,55(6):865-875. |
| APA | Zhang Shulan.,Luo Jing.,Li Ji.,Wu Ziyan.,Hu Chaojun.,...&Li Yongzhe.(2017).Retrospective evaluation of the clinical utility of serological biomarkers in Chinese patients with inflammatory bowel disease: 2-year clinical experience.,55(6),865-875. |
| MLA | Zhang Shulan,et al."Retrospective evaluation of the clinical utility of serological biomarkers in Chinese patients with inflammatory bowel disease: 2-year clinical experience".55.6(2017):865-875. |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论